HPGD and pancreatic ductal adenocarcinoma: The accumulation of prostaglandin E2 (PGE2) by inhibition of the degradation enzyme 15-hydroxyprostaglandin dehydrogenase (15-PGDH) induces progression of pancreatic ductal adenocarcinoma (PDAC) [34].